Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT05039177
Title A Study of ERAS-007 in Patients With Advanced Gastrointestinal Malignancies (HERKULES-3)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Erasca, Inc.

colorectal cancer


Cetuximab + Encorafenib + ERAS-007

ERAS-007 + Palbociclib

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST